Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss and polycystic ovary syndrome are often linked.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

PRP and minoxidil are similarly effective for hair density, but PRP has higher patient satisfaction.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

VLDL could be an early warning sign for male pattern baldness.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Oral testosterone therapy raises heart risk more than other methods.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

Finasteride use may increase depression and suicide risk, especially at 1 mg, so monitoring is advised.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Smoking increases the risk of male pattern hair loss.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

No single treatment is clearly effective for central serous chorioretinopathy.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Neuropathic pain is common in long COVID patients, especially those with depression or severe COVID-19.

Avemar may help in cancer treatment, but its effectiveness isn't proven yet.

COVID-19 vaccines caused mostly mild side effects in Bangladeshi medical students, with fewer issues after more doses.

Photobiomodulation may improve certain health conditions, but more high-quality research is needed.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Depression and skin autoimmune diseases are linked, needing combined care for better treatment.